Testing effectiveness (Phase 2)Study completedNCT05635734What this trial is testingAzeliragon and Chemoradiotherapy in Newly Diagnosed GlioblastomaWho this might be right forGlioblastoma Cantex Pharmaceuticals 33
Testing effectiveness (Phase 2)Study completedNCT00643097What this trial is testingVaccine Therapy in Treating Patients With Newly Diagnosed Glioblastoma MultiformeWho this might be right forMalignant Neoplasms of Brain John Sampson 40
Testing effectiveness (Phase 2)Study completedNCT00486603What this trial is testingHydroxychloroquine, Radiation, and Temozolomide Treating Patients With Newly Diagnosed Glioblastoma MultiformeWho this might be right forBrain and Central Nervous System Tumors Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 92
Testing effectiveness (Phase 2)Study completedNCT00128700What this trial is testingTemozolomide and Radiation Therapy With or Without Vatalanib in Treating Patients With Newly Diagnosed Glioblastoma MultiformeWho this might be right forBrain and Central Nervous System Tumors European Organisation for Research and Treatment of Cancer - EORTC 20
Post-approval studies (Phase 4)UnknownNCT05235737What this trial is testingThe Assessment of Immune Response in Newly Diagnosed Glioblastoma Patients Treated With PembrolizumabWho this might be right forNewly Diagnosed Glioblastoma Medical University of Silesia 36
Not applicableEnded earlyNCT00471653What this trial is testingPharmacokinetics in Patients With Newly Diagnosed High-Grade Glioma Receiving Temozolomide and Radiation TherapyWho this might be right forBrain and Central Nervous System TumorsThrombocytopenia Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 10
Early research (Phase 1)Study completedNCT00004212What this trial is testingDX-8951f in Treating Children With Advanced Solid Tumors or LymphomasWho this might be right forBrain and Central Nervous System TumorsLymphomaUnspecified Childhood Solid Tumor, Protocol Specific Daiichi Sankyo
Testing effectiveness (Phase 2)Active Not RecruitingNCT04195139What this trial is testingNivolumab and Temozolomide Versus Temozolomide Alone in Newly Diagnosed Elderly Patients With GBMWho this might be right forGlioblastoma Multiforme University of Sydney 103
Testing effectiveness (Phase 2)Study completedNCT02206230What this trial is testingTrial of Hypofractionated Radiation Therapy for GlioblastomaWho this might be right forGlioblastoma AHS Cancer Control Alberta 133